David Francis Carroll is CFO at IVERIC bio, Inc. (ISEE). They have made 14 open-market trades across 2 companies since 2017, most recently 2023-07-11.
CIK 0001703623
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 14 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ISEE | SELL · 10b5-1 | 2023-05-01 | 2023-05-03 | $37.04 | $2.4M | +0.9% | +2.1% | N/A |
| ISEE | SELL · 10b5-1 | 2023-04-21 | 2023-04-25 | $30.21 | $3.0M | +23.4% | +22.4% | N/A |
| ISEE | SELL | 2023-01-03 | 2023-01-04 | $20.06 | $145K | -0.5% | +17.7% | +32.9% |
| ISEE | SELL | 2022-12-19 | 2022-12-20 | $21.51 | $244K | -10.9% | -13.4% | +5.5% |
| ISEE | SELL | 2022-12-12 | 2022-12-13 | $21.49 | $297K | -0.7% | -9.5% | +1.2% |
| ISEE | SELL | 2022-04-01 | 2022-04-05 | $18.51 | $1.7M | -7.9% | -27.1% | -43.5% |
| ISEE | SELL | 2022-03-25 | 2022-03-29 | $17.02 | $571K | +6.4% | -13.3% | -37.5% |
| ISEE | SELL | 2022-03-18 | 2022-03-22 | $17.00 | $197K | +7.8% | -8.2% | -41.2% |
| ISEE | SELL | 2022-01-03 | 2022-01-04 | $16.39 | $519K | -7.8% | -8.0% | +27.5% |
| ISEE | SELL | 2021-12-21 | 2021-12-23 | $15.98 | $1.8M | -15.1% | -24.7% | -4.3% |
| ISEE | SELL | 2021-12-20 | 2021-12-21 | $15.44 | $207K | +3.6% | -21.6% | -1.6% |
| ISEE | SELL | 2021-12-13 | 2021-12-14 | $14.74 | $172K | +13.9% | -10.0% | -3.0% |
| ISEE | SELL | 2021-01-04 | 2021-01-05 | $6.85 | $163K | -13.6% | -14.7% | -3.5% |
| ISEE | SELL | 2019-07-02 | 2019-07-03 | $1.25 | $3K | -2.4% | -8.7% | -14.2% |
| OPHT | SELL | 2018-07-02 | 2018-07-03 | $2.68 | $7K | -4.0% | -13.0% | -14.4% |
| OPHT | SELL | 2017-07-05 | 2017-07-05 | $2.58 | $8K | +1.1% | -3.1% | +4.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.